China Cord Blood Reports Adoption Of 10b5-1 Sales Plan - Quick Facts

(RTTNews) - China Cord Blood Corp. (CO) announced that Magnum Opus Second Limited, an entity holding ordinary shares on behalf of certain directors and members of senior management, has adopted a 10b5-1 sales plan to sell up to 2,275,700 ordinary shares from time to time in ordinary brokerage transactions, primarily to meet the individuals' personal needs. The company said it has recommended a 10b5-1 sales plan for directors and members of senior management in order to comply with insider trading principles and reduce the possibility of opportunistic selling by management.

In accordance with the 10b5-1 sales plan, the trustee intends to sell up to an aggregate of 2,275,700 ordinary shares over time, representing approximately 1.9% of the company's total outstanding shares as of August 2017.